Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States. It provides psychedelic-enhanced holistic methodologies for the treatment of palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025. Aibotics Inc. is based in Miami, Florida.
Frequently asked questions
What sector does Aibotics Inc. (AIBT) operate in?
Aibotics Inc. belongs to the Other sector and operates in the Leisure industry.
What is Aibotics Inc. (AIBT) current stock price?
As of the latest data, Aibotics Inc. stock price is $0.00, with a previous close of $0.00. Aibotics Inc. gained $0.00 in the last trading session, representing a 11.54% increase.
What is Aibotics Inc. (AIBT) current market capitalization?
Aibotics Inc. market cap is approximately 2.58 million.
What is Aibotics Inc. (AIBT) Earnings Per Share (EPS)?
The trailing EPS is $0.01.
What is Aibotics Inc. (AIBT) Price-to-Earnings (P/E) ratio?
Aibotics Inc. current P/E ratio is 0.29.
What is Aibotics Inc. (AIBT) EBITDA?
Aibotics Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -253.03 thousand.
Does Aibotics Inc. (AIBT) pay dividends?
No. Aibotics Inc. does not pay a dividend.
What is Aibotics Inc. (AIBT) beta (volatility) score?
Aibotics Inc. has a beta of 0.729, indicating lower volatility than the overall market.